142.54
-5.01 (-3.40%)
Previous Close | 147.55 |
Open | 147.26 |
Volume | 983,612 |
Avg. Volume (3M) | 698,138 |
Market Cap | 7,743,458,304 |
Price / Sales | 3.65 |
Price / Book | 7.61 |
52 Weeks Range | |
Earnings Date | 4 Nov 2025 |
Profit Margin | -23.25% |
Operating Margin (TTM) | 21.69% |
Diluted EPS (TTM) | -5.45 |
Quarterly Revenue Growth (YOY) | 9.50% |
Quarterly Earnings Growth (YOY) | -7.50% |
Total Debt/Equity (MRQ) | 72.01% |
Current Ratio (MRQ) | 2.17 |
Operating Cash Flow (TTM) | 181.70 M |
Levered Free Cash Flow (TTM) | 139.68 M |
Return on Assets (TTM) | 1.32% |
Return on Equity (TTM) | -25.07% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Devices (US) | Mixed | Bearish |
Medical Devices (Global) | Mixed | Bearish | |
Stock | Masimo Corporation | Bullish | Bullish |
AIStockmoo Score
Analyst Consensus | 5.0 |
Insider Activity | -3.0 |
Price Volatility | 0.5 |
Technical Moving Averages | 2.5 |
Technical Oscillators | 2.0 |
Average | 1.40 |
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies. |
|
Sector | Healthcare |
Industry | Medical Devices |
Investment Style | Small Core |
% Held by Insiders | 7.88% |
% Held by Institutions | 101.46% |
Ownership
Name | Date | Shares Held |
---|---|---|
Politan Capital Management Lp | 30 Jun 2025 | 4,716,536 |
52 Weeks Range | ||
Price Target Range | ||
High | 210.00 (Piper Sandler, 47.33%) | Buy |
Median | 204.00 (43.12%) | |
Low | 198.00 (BTIG, 38.91%) | Buy |
Average | 204.00 (43.12%) | |
Total | 2 Buy | |
Avg. Price @ Call | 145.43 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
BTIG | 11 Sep 2025 | 198.00 (38.91%) | Buy | 146.21 |
Piper Sandler | 06 Aug 2025 | 210.00 (47.33%) | Buy | 144.65 |
Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
---|---|---|---|---|
TRIPODI BLAIR | - | 140.36 | -8,078 | -1,133,828 |
Aggregate Net Quantity | -8,078 | |||
Aggregate Net Value ($) | -1,133,828 | |||
Aggregate Avg. Buy ($) | - | |||
Aggregate Avg. Sell ($) | 140.36 |
Name | Holder | Date | Type | Quantity | Price | Value ($) |
---|---|---|---|---|---|---|
TRIPODI BLAIR | Officer | 23 Sep 2025 | Disposed (-) | 8,078 | 140.36 | 1,133,828 |
TRIPODI BLAIR | Officer | 23 Sep 2025 | Option execute | 15,000 | - | - |
Date | Type | Details |
---|---|---|
23 Sep 2025 | Announcement | Masimo Completes Sale of Consumer Audio Business to HARMAN International |
17 Sep 2025 | Announcement | New Study Finds That Using Masimo Technologies to Continuously Monitor General Floor Patients Reduces Costs |
11 Sep 2025 | Announcement | Masimo Announces Expansion of Strategic Partnership with Philips |
28 Aug 2025 | Announcement | Masimo to Present in the Wells Fargo Healthcare Conference |
19 Aug 2025 | Announcement | Masimo O3® Regional Oximetry Receives FDA Clearance for Expanded Indication of Its Unique Delta Hemoglobin Parameters |
22 Jul 2025 | Announcement | Masimo to Report Second Quarter 2025 Financial Results after Market Close on Tuesday, August 5 |
08 Jul 2025 | Announcement | Masimo Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |